TTLL8
gene geneOn this page
Summary
TTLL8 (tubulin tyrosine ligase like 8, HGNC:34000) is a protein-coding gene on chromosome 22q13.33, encoding Protein monoglycylase TTLL8 (A6PVC2). Monoglycylase which modifies both tubulin and non-tubulin proteins, adding a single glycine to the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of target proteins.
Predicted to enable protein-glycine ligase activity, initiating. Predicted to be involved in several processes, including axoneme assembly; flagellated sperm motility; and protein polyglycylation. Predicted to act upstream of or within cilium assembly. Predicted to be located in cilium. Predicted to be active in axoneme; microtubule cytoskeleton; and sperm flagellum.
Source: NCBI Gene 164714 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001350317
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34000 |
| Approved symbol | TTLL8 |
| Name | tubulin tyrosine ligase like 8 |
| Location | 22q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000138892 |
| Ensembl biotype | protein_coding |
| OMIM | 619193 |
| Entrez | 164714 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000433387, ENST00000477219
RefSeq mRNA: 1 — MANE Select: NM_001350317
NM_001350317
CCDS: CCDS93183
Canonical transcript exons
ENST00000433387 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000935803 | 50033202 | 50033445 |
| ENSE00000935804 | 50031686 | 50032109 |
| ENSE00001291365 | 50041621 | 50041807 |
| ENSE00001327607 | 50045856 | 50045970 |
| ENSE00001366757 | 50030430 | 50030925 |
| ENSE00001375695 | 50045255 | 50045389 |
| ENSE00001376558 | 50050109 | 50050247 |
| ENSE00001381515 | 50055234 | 50055325 |
| ENSE00001383828 | 50047168 | 50047296 |
| ENSE00001628946 | 50034357 | 50034505 |
| ENSE00001778004 | 50056869 | 50056973 |
| ENSE00003690167 | 50049249 | 50049322 |
| ENSE00003977023 | 50018575 | 50018791 |
| ENSE00003977272 | 50058154 | 50058298 |
Expression profiles
Bgee: expression breadth broad, 44 present calls, max score 97.83.
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.83 | gold quality |
| right testis | UBERON:0004534 | 72.62 | gold quality |
| left testis | UBERON:0004533 | 71.70 | gold quality |
| testis | UBERON:0000473 | 71.48 | gold quality |
| bone marrow cell | CL:0002092 | 43.85 | gold quality |
| sural nerve | UBERON:0015488 | 40.62 | gold quality |
| vermiform appendix | UBERON:0001154 | 40.31 | gold quality |
| tonsil | UBERON:0002372 | 38.94 | gold quality |
| lymph node | UBERON:0000029 | 38.50 | gold quality |
| bone marrow | UBERON:0002371 | 37.93 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.22 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.74 | gold quality |
| monocyte | CL:0000576 | 33.77 | gold quality |
| leukocyte | CL:0000738 | 33.21 | gold quality |
| muscle tissue | UBERON:0002385 | 33.17 | gold quality |
| duodenum | UBERON:0002114 | 32.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.32 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| mucosa of stomach | UBERON:0001199 | 31.81 | gold quality |
| left uterine tube | UBERON:0001303 | 30.70 | gold quality |
| liver | UBERON:0002107 | 30.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 30.43 | silver quality |
| fundus of stomach | UBERON:0001160 | 30.34 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| frontal cortex | UBERON:0001870 | 29.87 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ttll6 | ENSDARG00000054023 |
| mus_musculus | Ttll8 | ENSMUSG00000022388 |
| rattus_norvegicus | Ttll8 | ENSRNOG00000032311 |
| drosophila_melanogaster | TTLL3B | FBGN0031853 |
| drosophila_melanogaster | TTLL3A | FBGN0031854 |
| drosophila_melanogaster | TTLL15 | FBGN0037838 |
| drosophila_melanogaster | TTLL6B | FBGN0039501 |
| caenorhabditis_elegans | WBGENE00010630 |
Paralogs (12): TTLL1 (ENSG00000100271), TTLL12 (ENSG00000100304), TTLL2 (ENSG00000120440), TTLL9 (ENSG00000131044), TTLL4 (ENSG00000135912), TTLL7 (ENSG00000137941), TTLL10 (ENSG00000162571), TTLL6 (ENSG00000170703), TTLL11 (ENSG00000175764), KPRP (ENSG00000203786), TTLL13 (ENSG00000213471), TTLL3 (ENSG00000214021)
Protein
Protein identifiers
Protein monoglycylase TTLL8 — A6PVC2 (reviewed: A6PVC2)
Alternative names: Tubulin–tyrosine ligase-like protein 8
All UniProt accessions (1): A0A1C7CYW9
UniProt curated annotations — full annotation on UniProt →
Function. Monoglycylase which modifies both tubulin and non-tubulin proteins, adding a single glycine to the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of target proteins. Not involved in elongation step of the polyglycylation reaction. Preferentially monoglycylates alpha-tubulin over beta-tubulin. Together with TTLL3, mediates microtubule glycylation of primary and motile cilia, which is essential for their stability and maintenance. Together with TTLL3, glycylates sperm flagella which regulates axonemal dynein motor activity, thereby controlling flagellar beat, directional sperm swimming and male fertility. Monoglycylates non-tubulin proteins such as ANP32A, ANP32B, SET, NCL and NAP1.
Subcellular location. Cytoplasm. Cytoskeleton. Cell projection. Cilium. Cilium axoneme. Flagellum axoneme.
Domain organisation. Two conserved structural elements specific among monoglycylases, IS1 and IS2, are involved in glycyl chains initiation. Two conserved structural interfaces likely constitute the binding platforms for tubulin tail and microtubule. Arg-360 is the main determinant for regioselectivity, which segregates between initiases and elongases in all tubulin–tyrosine ligase family. A glutamine residue at this position is found in elongases TTLL6, TTLL9, TTLL11, TTLL13, TTLL10 and favors glutamate-chain elongation, whereas an arginine residue is found in initiases TTLL2, TTLL4, TTLL5, TTLL3, TTLL8 and favors initiation.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6PVC2-1 | 1 | yes |
| A6PVC2-2 | 2 |
RefSeq proteins (1): NP_001337246* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004344 | TTL/TTLL_fam | Family |
| IPR051437 | TTLL_monoglycylase | Family |
Pfam: PF03133
Catalyzed reactions (Rhea), 1 shown:
- L-glutamyl-[protein] + glycine + ATP = glycyl-L-glutamyl-[protein] + ADP + phosphate + H(+) (RHEA:67180)
UniProt features (23 total): binding site 11, splice variant 3, region of interest 3, sequence variant 3, chain 1, domain 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6PVC2-F1 | 70.64 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 360 (essential for specifying initiation versus elongation step of the glycylase activity)
Ligand- & substrate-binding residues (11): 449–450; 527; 540; 540; 540; 542; 354; 360–361; 360; 392–395; 405–407
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin |
MSigDB gene sets: 56 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_MALE_GAMETE_GENERATION, NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS, GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY, GOCC_CYTOPLASMIC_REGION
GO Biological Process (6): spermatogenesis (GO:0007283), protein polyglycylation (GO:0018094), flagellated sperm motility (GO:0030317), axoneme assembly (GO:0035082), protein modification process (GO:0036211), cilium assembly (GO:0060271)
GO Molecular Function (6): ATP binding (GO:0005524), metal ion binding (GO:0046872), protein-glycine ligase activity (GO:0070735), protein-glycine ligase activity, initiating (GO:0070736), nucleotide binding (GO:0000166), ligase activity (GO:0016874)
GO Cellular Component (9): cytosol (GO:0005829), microtubule (GO:0005874), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), sperm flagellum (GO:0036126), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), motile cilium (GO:0031514)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoskeleton | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| peptidyl-glutamic acid modification | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| protein metabolic process | 1 |
| macromolecule modification | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| cation binding | 1 |
| acid-amino acid ligase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| protein-glycine ligase activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| 9+2 motile cilium | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
276 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TTLL8 | LRRC63 | Q05C16 | 529 |
| TTLL8 | ANKRD60 | Q9BZ19 | 493 |
| TTLL8 | SPATA31A1 | Q5TZJ5 | 480 |
| TTLL8 | CCDC74B | Q96LY2 | 471 |
| TTLL8 | C12orf42 | Q96LP6 | 454 |
| TTLL8 | SVBP | Q8N300 | 433 |
| TTLL8 | FAM47C | Q5HY64 | 419 |
| TTLL8 | ATAT1 | Q5SQI0 | 413 |
| TTLL8 | TTLL4 | Q14679 | 409 |
| TTLL8 | TTLL12 | Q14166 | 391 |
| TTLL8 | CCDC149 | Q6ZUS6 | 391 |
| TTLL8 | ZNF775 | Q96BV0 | 381 |
| TTLL8 | SHISA8 | B8ZZ34 | 380 |
| TTLL8 | ARMC3 | Q5W041 | 356 |
| TTLL8 | SUN3 | Q8TAQ9 | 350 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1W2PPD8, A2A3K4, A4Q9E5, A4Q9F0, A4Q9F1, A6PVC2, A7E379, B2GUB3, D3YWQ0, F1MAB7, O00295, O15021, O75912, O89084, O94953, O94966, P03177, P15304, P46686, P54748, Q08493, Q0P4M4, Q14999, Q1ECV4, Q1HVD1, Q28969, Q3KSQ2, Q3ULB5, Q4G017, Q5R8Z4, Q5R978, Q5RCJ3, Q5TKR9, Q6EEF3, Q6EMB2, Q6J1Y9, Q6NZK8, Q6X4W1, Q6ZT98, Q7TNN8
Diamond homologs: A2APC3, A4Q9E4, A4Q9E5, A4Q9E8, A4Q9F6, A6NNM8, A6PVC2, A8CVX7, B2GUB3, O95922, P0CAZ0, Q0VC71, Q1ECV4, Q23K29, Q23SI8, Q3SXZ7, Q3SZH6, Q4R7H0, Q564U4, Q5PPI9, Q5R978, Q641W7, Q6EEF3, Q6EMB2, Q8CHB8, Q8N841, Q91V51, Q9BWV7, Q9Y4R7, A4Q9F0, A4Q9F1, A4Q9F4, A8X9V4, E9P886, F7E540, H2KZM9, P38160, P38584, Q09647, Q14679
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
5561 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000019421 (22:50026317 G>A,T), RS1000162593 (22:50031471 C>T), RS1000200873 (22:50045067 T>C), RS1000230196 (22:50023641 C>T), RS1000275981 (22:50057354 T>A,G), RS1000348934 (22:50056892 T>A,C), RS1000431511 (22:50033751 G>A), RS1000467628 (22:50030293 G>A,T), RS1000486102 (22:50046081 A>C), RS1000630575 (22:50058326 G>T), RS1000670478 (22:50026239 G>A,C), RS1000687569 (22:50058528 C>T), RS1000706593 (22:50023811 G>C), RS1000767736 (22:50035853 C>T), RS1000796890 (22:50018842 A>G)
Disease associations
OMIM: gene MIM:619193 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003472_18 | Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder | 7.000000e-06 |
| GCST004133_55 | Ulcerative colitis | 2.000000e-10 |
| GCST004766_26 | Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes | 8.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007679 | oppositional defiant disorder measurement |
| EFO:0007681 | triglyceride change measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| benzo(e)pyrene | increases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | affects methylation, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Smoke | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | increases abundance, affects methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.